0001557746-15-000001.txt : 20150911 0001557746-15-000001.hdr.sgml : 20150911 20150911154554 ACCESSION NUMBER: 0001557746-15-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150911 DATE AS OF CHANGE: 20150911 EFFECTIVENESS DATE: 20150911 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aclaris Therapeutics, Inc. CENTRAL INDEX KEY: 0001557746 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 460571712 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-247471 FILM NUMBER: 151103370 BUSINESS ADDRESS: STREET 1: SUITE 400, 101 LINDENWOOD DRIVE CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 484-321-5554 MAIL ADDRESS: STREET 1: SUITE 400, 101 LINDENWOOD DRIVE CITY: MALVERN STATE: PA ZIP: 19355 D 1 primary_doc.xml X0707 D LIVE 0001557746 Aclaris Therapeutics, Inc. 101 Lindenwood Drive Suite 400 MALVERN PA PENNSYLVANIA 19355 484-324-7933 DELAWARE None None Corporation true 2012 Neal Walker c/o Aclaris Therapeutics, Inc. 101 Lindenwood Drive, Suite 400 Malvern PA PENNSYLVANIA 19355 Executive Officer Director Christopher Powala c/o Aclaris Therapeutics, Inc. 101 Lindenwood Drive, Suite 400 Malvern PA PENNSYLVANIA 19355 Executive Officer Stuart D. Shanler c/o Aclaris Therapeutics, Inc. 101 Lindenwood Drive, Suite 400 Malvern PA PENNSYLVANIA 19355 Executive Officer Kamil Ali-Jackson c/o Aclaris Therapeutics, Inc. 101 Lindenwood Drive, Suite 400 Malvern PA PENNSYLVANIA 19355 Executive Officer Frank Ruffo c/o Aclaris Therapeutics, Inc. 101 Lindenwood Drive, Suite 400 Malvern PA PENNSYLVANIA 19355 Executive Officer Stephen A. Tullman c/o Aclaris Therapeutics, Inc. 101 Lindenwood Drive, Suite 400 Malvern PA PENNSYLVANIA 19355 Director Albert Cha c/o Aclaris Therapeutics, Inc. 101 Lindenwood Drive, Suite 400 Malvern PA PENNSYLVANIA 19355 Director Anand Mehra c/o Aclaris Therapeutics, Inc. 101 Lindenwood Drive, Suite 400 Malvern PA PENNSYLVANIA 19355 Director Christopher Molineaux c/o Aclaris Therapeutics, Inc. 101 Lindenwood Drive, Suite 400 Malvern PA PENNSYLVANIA 19355 Director Ketan Patel c/o Aclaris Therapeutics, Inc. 101 Lindenwood Drive, Suite 400 Malvern PA PENNSYLVANIA 19355 Director Pharmaceuticals Decline to Disclose 06b false 2015-08-28 false true true Offer and sale of Series C Preferred Stock, and the underlying shares of Common Stock issuable upon conversion thereof. false 0 40000000 40000000 0 false 28 0 0 1800000 true false Aclaris Therapeutics, Inc. /s/Kamil Ali-Jackson Kamil Ali-Jackson Chief Legal Officer & Secretary 2015-09-11